Proteonomix, Inc. Announces Critical Patent Filing.
MOUNTAINSIDE, NJ--(Marketwire - 10/08/10) - Proteonomix, Inc. (OTC.BB:PROT - News) ("Proteonomix" or the "Company") announced today that it has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.
